South Korea · Delayed Price · Currency is KRW Verve Therapeutics Statistics
Total Valuation
Solborn has a market cap or net worth of KRW 106.39 billion. The enterprise value is 42.35 billion.
| Market Cap | 106.39B |
| Enterprise Value | 42.35B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Solborn has 25.67 million shares outstanding. The number of shares has decreased by -0.07% in one year.
| Current Share Class | 25.67M |
| Shares Outstanding | 25.67M |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 38.52% |
| Owned by Institutions (%) | 0.16% |
| Float | 6.08M |
Valuation Ratios
The trailing PE ratio is 4.39.
| PE Ratio | 4.39 |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | 7.77 |
| P/OCF Ratio | 7.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.85, with an EV/FCF ratio of 3.09.
| EV / Earnings | 2.20 |
| EV / Sales | 0.35 |
| EV / EBITDA | 1.85 |
| EV / EBIT | 2.10 |
| EV / FCF | 3.09 |
Financial Position
The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.09 |
| Quick Ratio | 4.93 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.24 |
| Interest Coverage | 155.26 |
Financial Efficiency
Return on equity (ROE) is 14.64% and return on invested capital (ROIC) is 4.69%.
| Return on Equity (ROE) | 14.64% |
| Return on Assets (ROA) | 4.02% |
| Return on Invested Capital (ROIC) | 4.69% |
| Return on Capital Employed (ROCE) | 6.69% |
| Revenue Per Employee | 30.29B |
| Profits Per Employee | 4.82B |
| Employee Count | 4 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 34.09 |
Taxes
In the past 12 months, Solborn has paid 7.76 billion in taxes.
| Income Tax | 7.76B |
| Effective Tax Rate | 16.63% |
Stock Price Statistics
The stock price has increased by +12.16% in the last 52 weeks. The beta is 0.95, so Solborn's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +12.16% |
| 50-Day Moving Average | 4,214.80 |
| 200-Day Moving Average | 3,991.73 |
| Relative Strength Index (RSI) | 41.85 |
| Average Volume (20 Days) | 43,469 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Solborn had revenue of KRW 121.16 billion and earned 19.29 billion in profits. Earnings per share was 865.29.
| Revenue | 121.16B |
| Gross Profit | 72.47B |
| Operating Income | 20.22B |
| Pretax Income | 46.66B |
| Net Income | 19.29B |
| EBITDA | 22.92B |
| EBIT | 20.22B |
| Earnings Per Share (EPS) | 865.29 |
Balance Sheet
The company has 154.24 billion in cash and 3.28 billion in debt, giving a net cash position of 150.96 billion or 5,881.58 per share.
| Cash & Cash Equivalents | 154.24B |
| Total Debt | 3.28B |
| Net Cash | 150.96B |
| Net Cash Per Share | 5,881.58 |
| Equity (Book Value) | 285.57B |
| Book Value Per Share | 7,739.28 |
| Working Capital | 148.95B |
Cash Flow
In the last 12 months, operating cash flow was 14.21 billion and capital expenditures -513.98 million, giving a free cash flow of 13.70 billion.
| Operating Cash Flow | 14.21B |
| Capital Expenditures | -513.98M |
| Free Cash Flow | 13.70B |
| FCF Per Share | 533.67 |
Margins
Gross margin is 59.81%, with operating and profit margins of 16.69% and 15.92%.
| Gross Margin | 59.81% |
| Operating Margin | 16.69% |
| Pretax Margin | 38.51% |
| Profit Margin | 15.92% |
| EBITDA Margin | 18.91% |
| EBIT Margin | 16.69% |
| FCF Margin | 11.31% |
Dividends & Yields
Solborn does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | n/a |
| Earnings Yield | 18.13% |
| FCF Yield | 12.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 30, 2005. It was a reverse split with a ratio of 0.7536.
| Last Split Date | Jun 30, 2005 |
| Split Type | Reverse |
| Split Ratio | 0.7536 |
Scores
Solborn has an Altman Z-Score of 2.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.55 |
| Piotroski F-Score | 4 |